Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 10:22AM ET
Dollar change
Percentage change
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y-9.52% Shs Outstand Perf Week-1.23%
SponsorWisdom Tree ETF Type Tagsequity Return% 3Y-12.86% Total Holdings100 Perf Month4.47%
Fund Family Bond Type Tagsbiotechnology Return% 5Y- AUM2.47M Perf Quarter7.85%
IndexWisdomTree BioRevolution Index Average Maturity Tags- Return% 10Y NAV% Perf Half Y4.15%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year-10.68%
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range13.37 - 18.52 Perf YTD-2.92%
Dividend TTM0.14 (0.82%) ESG Type Tags- Flows% 3M0.00% 52W High-11.61% Beta1.05
Dividend Ex-DateDec 22, 2023 Dividend Type Sector/Theme Flows% YTD-6.33% 52W Low22.42% ATR (14)0.22
Expense0.45% Structure Type Region Flows% 1Y RSI (14)53.05 Volatility1.38% 0.85%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.19 Prev Close16.45
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume0.97K Price16.37
SMA201.78% SMA501.45% SMA2002.73% Trades Volume145 Change-0.49%
WisdomTree BioRevolution Fund seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index ("index"). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.